Biophytis SA 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

OTC.Pink
Biophytis S.A. releases its 20-F filing, detailing financial results, ongoing clinical programs, and future strategies in the biotechnology sector.